8dzc: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 4: | Line 4: | ||
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[8dzc]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Severe_acute_respiratory_syndrome_coronavirus_2 Severe acute respiratory syndrome coronavirus 2]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=8DZC OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=8DZC FirstGlance]. <br> | <table><tr><td colspan='2'>[[8dzc]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Severe_acute_respiratory_syndrome_coronavirus_2 Severe acute respiratory syndrome coronavirus 2]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=8DZC OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=8DZC FirstGlance]. <br> | ||
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=U76:(3,5-difluorophenyl)methyl+{(3S)-1-[(2S)-1-({(2S,3R)-4-(cyclopropylamino)-3-hydroxy-4-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl}amino)-4-methyl-1-oxopentan-2-yl]-6-oxopiperidin-3-yl}carbamate'>U76</scene></td></tr> | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.2Å</td></tr> | ||
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=U76:(3,5-difluorophenyl)methyl+{(3S)-1-[(2S)-1-({(2S,3R)-4-(cyclopropylamino)-3-hydroxy-4-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl}amino)-4-methyl-1-oxopentan-2-yl]-6-oxopiperidin-3-yl}carbamate'>U76</scene></td></tr> | |||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=8dzc FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=8dzc OCA], [https://pdbe.org/8dzc PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=8dzc RCSB], [https://www.ebi.ac.uk/pdbsum/8dzc PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=8dzc ProSAT]</span></td></tr> | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=8dzc FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=8dzc OCA], [https://pdbe.org/8dzc PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=8dzc RCSB], [https://www.ebi.ac.uk/pdbsum/8dzc PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=8dzc ProSAT]</span></td></tr> | ||
</table> | </table> | ||
| Line 11: | Line 12: | ||
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
SARS-CoV-2 is still wreaking havoc all over the world with surging morbidity and high mortality. The main protease ( | SARS-CoV-2 is still wreaking havoc all over the world with surging morbidity and high mortality. The main protease (M(pro) ) is essential in the replication of SARS-CoV-2, enabling itself an active target for antiviral development. Herein, we reported the design and synthesis of a new class of peptidomimetics-constrained alpha, gamma-AA peptides, based on which a series of aldehyde and ketoamide inhibitors of the M(pro) of SARS-CoV-2 were prepared. The lead compounds showed excellent inhibitory activity in the FRET-based M(pro) enzymatic assay not only for the M(pro) of SARS-CoV-2 but also for SARS-CoV and MERS-CoV, along with HCoVs like HCoV-OC43, HCoV-229E, HCoV-NL63 and HKU1. The X-ray crystallographic results demonstrated that our compounds form a covalent bond with the catalytic Cys145. They also demonstrated effective antiviral activity against live SARS-CoV-2. Overall, the results suggest that alpha, gamma-AA peptide could be a promising molecular scaffold in designing novel M(pro) inhibitors of SARS-CoV-2 and other coronaviruses. | ||
Development of the Safe and Broad-Spectrum Aldehyde and Ketoamide Mpro inhibitors Derived from the Constrained alpha, gamma-AA Peptide Scaffold.,Wang L, Ma C, Sacco MD, Xue S, Mahmoud M, Calcul L, Chen Y, Wang J, Cai J Chemistry. 2023 | Development of the Safe and Broad-Spectrum Aldehyde and Ketoamide Mpro inhibitors Derived from the Constrained alpha, gamma-AA Peptide Scaffold.,Wang L, Ma C, Sacco MD, Xue S, Mahmoud M, Calcul L, Chen Y, Wang J, Cai J Chemistry. 2023 Jun 22;29(35):e202300476. doi: 10.1002/chem.202300476. Epub 2023 , May 5. PMID:36920943<ref>PMID:36920943</ref> | ||
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
Latest revision as of 11:54, 30 October 2024
Crystal structure of the SARS-CoV-2 (COVID-19) main protease in complex with inhibitor 17
| ||||||||||||